Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Pricing Insights
Enjoy your FREE PREVIEW which shows only 2021 data and 25 documents. For full access, try it free at any time.        

AI Biotech/Diagnostics: Cardio

Read More News and Insights

uBiome needs a cure

AI Biotech/Diagnostics: Cardio Patent Forecast®

May 9, 2019

As expected for the #1 patent holder in the AI Biotech/Diagnostics sector, uBiome has been growing at a stunning pace, raising millions from investors, partnering with L'Oréal, and collecting numerous microbiome samples from around the world. However, the Silicon Valley healthcare startup is now facing unprecedented uncertainty. Many of its customers have complained about its billing practices over the past few years, the FBI raided its offices last month, and its two cofounders/co-CEOs are on "administrative leave." Although uBiome's questionable billing practices may be unrelated to the quality of its products, this crisis begs the question of what will happen to the business and its massive patent portfolio. Will uBiome continue to operate by relying on its technologies and customer base, or will it try to license its IP to other companies?

Relevant Patent Documents

Patent US10282520  

Article Source Link

Business Insider

Read more like this in News This Week!   or   Share this link with your connections!